Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Fortis Malar HospitalsBOM:523696 +1.21%31 5-Year Yield-on-Cost % is 0.00 as of Sep. 08, 2026. GuruFocus rates BOM:523696 with a GF Score™ of 31/100. The stock has 1 warning sign investors should review. Among 280 Healthcare Providers & Services companies, Fortis Malar Hospitals ranks worse than 357142.5% on this metric.
Fortis Malar Hospitals's yield on cost for the quarter that ended in Jun. 2026 was 0.00.
The historical rank and industry rank for Fortis Malar Hospitals's 5-Year Yield-on-Cost % or its related term are showing as below:
During the past 13 years, Fortis Malar Hospitals's highest Yield on Cost was 81.75. The lowest was 3.43. And the median was 63.25.
BOM:523696's 5-Year Yield-on-Cost % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.915 * Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Fortis Malar Hospitals 5-Year Yield-on-Cost % Related Terms
BOM:523696 vs HCA, THC, EHC: 5-Year Yield-on-Cost % Comparison
For the Medical Care Facilities subindustry, Fortis Malar Hospitals's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fortis Malar Hospitals 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Fortis Malar Hospitals's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Fortis Malar Hospitals's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Fortis Malar Hospitals (BOM:523696) has a 5-Year Yield-on-Cost % of 0.00 as of Sep. 08, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Fortis Malar Hospitals and its competitors. Over the past decade, Fortis Malar Hospitals' 5-Year Yield-on-Cost % has ranged from 3.43 to 81.75. According to the industry distribution chart, Fortis Malar Hospitals ranks #999999 out of 280 companies in the Healthcare Providers & Services industry.
Is Fortis Malar Hospitals' 5-Year Yield-on-Cost % too high?
Fortis Malar Hospitals' current 5-Year Yield-on-Cost % is 0.00. Over the past 10 years, this metric has ranged from a low of 3.43 to a high of 81.75. Based on the distribution chart, Fortis Malar Hospitals ranks #999999 out of 280 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Fortis Malar Hospitals has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Fortis Malar Hospitals' 5-Year Yield-on-Cost % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Fortis Malar Hospitals ranks #999999 out of 280 companies for 5-Year Yield-on-Cost %. This places Fortis Malar Hospitals in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.92. Historically, Fortis Malar Hospitals' own 5-Year Yield-on-Cost % has ranged from 3.43 to 81.75 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.92, based on 280 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Fortis Malar Hospitals and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fortis Malar Hospitals's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fortis Malar Hospitals stock overvalued right now?
Fortis Malar Hospitals (BOM:523696) has a current 5-Year Yield-on-Cost % of 0.00. The current 5-Year Yield-on-Cost % is 0.00. Fortis Malar Hospitals' overall GF Score™ is 31/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Fortis Malar Hospitals (BOM:523696), the current 5-Year Yield-on-Cost % is 0.00 as of Sep. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Fortis Malar Hospitals Ltd is an India-based company engaged in the provision of healthcare services. It focuses on providing medical care in the areas of cardiology and cardiac surgery, neurosurgery, gynecology, orthopedics, gastroenterology, neurology, pediatrics, diabetes, nephrology, and internal medicine. The company provides healthcare services in various branches of medicine such as general surgery, general medicine, pediatrics, neurology, cardiology, ophthalmology, radiology, pathology, gastroenterology, urology, thoracic surgery, plastic surgery, and other allied specialties. It operates in one business, namely, in the health care services.
31GF Score
Get the complete analysis for BOM:523696
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:523696 has been successfully added to your 
